KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Goodwill & Intangibles (2016 - 2025)

Historic Goodwill & Intangibles for Biomarin Pharmaceutical (BMRN) over the last 17 years, with Q3 2025 value amounting to $429.3 million.

  • Biomarin Pharmaceutical's Goodwill & Intangibles fell 608.33% to $429.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $429.3 million, marking a year-over-year decrease of 608.33%. This contributed to the annual value of $451.5 million for FY2024, which is 803.08% down from last year.
  • Biomarin Pharmaceutical's Goodwill & Intangibles amounted to $429.3 million in Q3 2025, which was down 608.33% from $435.8 million recorded in Q2 2025.
  • In the past 5 years, Biomarin Pharmaceutical's Goodwill & Intangibles ranged from a high of $602.1 million in Q1 2021 and a low of $429.3 million during Q3 2025
  • Moreover, its 5-year median value for Goodwill & Intangibles was $506.5 million (2023), whereas its average is $513.5 million.
  • Its Goodwill & Intangibles has fluctuated over the past 5 years, first tumbled by 422.19% in 2022, then plummeted by 1043.64% in 2023.
  • Biomarin Pharmaceutical's Goodwill & Intangibles (Quarter) stood at $584.9 million in 2021, then decreased by 8.56% to $534.8 million in 2022, then fell by 8.2% to $490.9 million in 2023, then decreased by 8.03% to $451.5 million in 2024, then dropped by 4.91% to $429.3 million in 2025.
  • Its Goodwill & Intangibles was $429.3 million in Q3 2025, compared to $435.8 million in Q2 2025 and $443.5 million in Q1 2025.